VivoSim Labs Prices Public Offering of Common Stock and Warrants for up to 3,508,772 Shares
VivoSim Labs announced the pricing of a best efforts public offering of up to 3,508,772 shares of common stock or pre-funded warrants, along with accompanying common warrants to purchase up to 5,263,159 shares. The initial tranche closed on April 1, 2026, issuing shares and pre-funded warrants with accompanying warrants at a combined price of $1.14 and $1.139, respectively, potentially providing the company with significant capital.
Key Highlights
- Offering includes common stock or pre-funded warrants and accompanying common warrants.
- Initial tranche closed on April 1, 2026, issuing 286,557 shares and 2,345,022 pre-funded warrants.
- Common warrants in the initial tranche have an exercise price of $1.71 per share.
Price Impact
More from VIVS
More in Equity Offering
One & one Green Technologies Secures $13M in Follow-on Offering from Institutional Investors, with Option for Additional $3M
Linkers Industries Completes Full Exercise of Series B Cashless Warrants, Resulting in 1.52M Class A Shares Outstanding
Annovis Bio Secures $10M Public Offering, Extends Cash Runway to Q2 2027, Funds NDA Submission with AD Phase 3 Trial 75% Enrolled